High-penetrance mouse model of acute promyelocytic leukemia with very low levels of PML-RARα expression

Blood

Volumn 102, Issue 5, 2003, Pages 1857-1865

  Westervelt, Peter ^b   Lane, Andrew A ^b   Pollock, Jessica L ^b   Oldfather, Kristie ^b   Holt, Matthew S ^b   Zimonjic, Drazen B ^b   Popescu, Nicholas C ^b   DiPersio, John F ^b   Ley, Timothy J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN G; COMPLEMENTARY DNA; MESSENGER RNA; RETINOIC ACID; RETINOIC ACID RECEPTOR ALPHA; RNA;

ACUTE LEUKEMIA; ANIMAL CELL; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CRYOPRESERVATION; FLOW CYTOMETRY; GENE DOSAGE; GENE EXPRESSION; GENE LOCUS; HUMAN; HUMAN CELL; LEUKEMOGENESIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN CELL; TRANSGENIC MOUSE; TUMOR CELL; WESTERN BLOTTING;

EID: 0042441182     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-12-3779     Document Type: Article

References (33)

1. Grisolano JL, Wesselschmidt RL, Pelicci PG, Ley TJ. Altered myeloid development and acute leukemia in transgenic mice expressing PML-RARα under control of cathepsin G regulatory sequences. Blood. 1997;89:376-387.
2. He L-Z, Tribioli C, Rivi R, et al. Acute leukemia with promyelocytic features in PML/RARα transgenic mice. Proc Natl Acad Sci U S A. 1997;94:5302-5307.
3. Brown D, Kogan S, Lagasse E, et al. A PML-RARα transgene initiates murine acute promyelocytic leukemia. Proc Natl Acad Sci U S A. 1997;94:2551-2556.
4. He L-Z, Guidez F, Tribioli C, et al. Distinct interactions of PML-RARalpha and PLZF-RARalpha with corepressors determine differential responses to RA in APL. Nat Genet. 1998;18:126-135.
5. Cheng G-X, Zhu X-H, Men X-Q, et al. Distinct leukemia phenotypes in transgenic mice and different corepressor interactions generated by promyelocytic leukemia variant fusion genes PLZF-RARα and NPM-RARα. Proc Natl Acad Sci U S A. 1999;96:6318-6323.
6. Pollock JL, Westervelt P, Kurichety AK, Pelicci PG, Grisolano JL, Ley TJ. A bcr-3 isoform of RARα-PML potentiates the development of PML-RARα-driven acute promyelocytic leukemia. Proc Natl Acad Sci U S A. 1999;96:15103-15108.
7. Pollock JL, Westervelt P, Walter MJ, Lane AA, Ley TJ. Mouse models of acute promyelocytic leukemia. Curr Opin Hematol. 2001;8:206-211.
8. Zimonjic DB, Pollock JL, Westervelt P, Popescu NC, Ley TJ. Acquired, nonrandom chromosomal abnormalities associated with the development of acute promyelocytic leukemia in transgenic mice. Proc Natl Acad Sci U S A. 2000;97:13306-13311.
9. Le Beau M, Bitts S, Davis EM, Kogan SC. Recurring chromosomal abnormalities in leukemia in PML-RARα transgenic mice parallel human acute promyelocytic leukemia. Blood. 2002;99:2985-2991.
10. Kogan SC, Brown DE, Schultz DB, et al. BCL-2 cooperates with promyelocytic leukemia retinoic acid recepter α chimeric protein (PMLRARα) to block neutrophil differentiation and initiate acute leukemia. J Exp Med. 2001;193:531-543.
11. Kelly LM, Kutok JL, Williams IR, et al. PML/RARα and FLT3-ITD induce an APL-like disease in a mouse model. Proc Natl Acad Sci U S A. 2002;99:8283-8288.
12. Melnick A, Licht JD. Deconstructing a disease: RARα, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood. 1999;93:3167-3215.
13. Pandolfi PP. Oncogenes and tumor suppressors in the molecular pathogenesis of acute promyelocytic leukemia. Hum Mol Genet. 2001;10:769-775.
14. Merghoub T, Gurrieri C, Pizaaz F, Pandolfi PP. Modeling acute promyelocytic leukemia in the mouse: new insights in the pathogenesis of human leukemias. Blood Cells Mol Dis. 2001;27:231-248.
15. Dyck JA, Maul GG, Miller WH Jr, Chen JD, Kakizuka A, Evans RM. A novel macromolecular structure is a target of the promyelocytic-retinoic acid receptor. Cell. 1964;76:333-343.
16. Weis K, Rambaud S, Lavau C, et al. Retinoic acid regulates aberrant nuclear localization of PML-RARα in acute promyelocytic leukemia cells. Cell. 1994;76:345-356.
17. Jansen JH, Mahfoudi A, Rambaud S, Lavau C, Wahli W, Dejean A. Multimeric complexes of the PML-retinoic acid receptor α fusion protein in acute promyelocytic leukemia cells and interference with retinoid and peroxisome-proliferator signaling pathways. Proc Natl Acad Sci U S A. 1995;92:7401-7405.
18. Rego EM, Wang Z-G, Peruzzi D, He L-Z, Cordon-Cardo C, Pandolfi PP. Role of promyelocytic leukemia (PML) protein in tumor suppression. J Exp Med. 2001;193:521-529.
19. Heusel JW, Scarpati EM, Jenkins NA, et al. Molecular cloning, chromosomal location, and tissue-specific expression of the murine cathepsin G gene. Blood. 1993;81:1614-1623.
20. Hug BA, Wesselschmidt RL, Fiering S, et al. Analysis of mice containing a targeted deletion of the β-globin locus control region 5′HS-3. Mol Cell Biol. 1996;16:2906-2912.
21. Maclvor DM, Shapiro SD, Pham CTN, Belaaouaj A, Abraham S, Ley TJ. Normal neutrophil function in cathepsin G deficient mice. Blood. 1999;94:4282-4293.
22. Zimonjic DB, Rezanka L, DiPaolo JA, Popescu NC. Refined localization of the erbB-3 protooncogene by direct visualization of FISH signals on LUT-inverted and contrast-enhanced digital images of DAPI-banded chromosomes. Cancer Genet Cytogenet. 1995;80:100-102.
23. Sigurdsson F, Khanna-Gupta A, Lawson N, Berliner N. Control of late neutrophil-specific gene expression: insights into regulation of myeloid differentiation. Semin Hematol. 1997;34:303-310.
24. Hanson RD, Connolly NL, Burnett D, Campbell EJ, Senior RM, Ley TJ. Developmental regulation of the human cathepsin G gene in myelomonocytic cells. J Biol Chem. 1990;265:1524-1530.
25. Zimmer M, Medcalf RL, Fink TM, Mattmann C, Lichter P, Jenne DE. Three human elastase-like genes coordinately expressed in the myelomonocytic lineage are organized as a single genetic locus on 19pter. Proc Natl Acad Sci U S A. 1992;89:8215-8219.
26. Grisolano JL, Sclar GM, Ley TJ. Early myeloidspecific expression of the human cathepsin G gene in transgenic mice. Proc Natl Acad Sci U S A. 1994;91:8989-8993.
27. Lane AA, westervelt P, Ley TJ. PML-RARα kills U937 cells: a novel activity of PML-RARα that may contribute to APL pathogenesis [abstract]. Blood. 2002;100:538a.
28. Grosveld F, van Assendelft GM, Greaves DR, Kollias G. Position-independent, high-level expression of the human β-globin gene in transgenic mice. Cell. 1987;51:975-985.
29. Hanscombe O, Vidal M, Kaeda J, Luzzatto L, Greaves DR, Grosveld F. High-level, erythroidspecific expression of the human α-globin gene in transgenic mice and the production of human hemoglobin in murine erythrocytes. Genes Dev. 1989;3:1572-1581.
30. Greaves DR, Fraser P, Vidal MA, et al. A transgenic mouse model of sickle cell disorder. Nature. 1990;343:183-185.
31. Grignani F, Ferrucci PF, Testa U, et al. The acute promyelocytic leukemia-specific PML-RARα fusion protein inhibits differentiation and promotes survival of myeloid precursor cells. Cell. 1993;74:423-431.
32. Ferrucci PR, Grignani F, Pearson M, Fagioli M, Nicoletti I, Pelicci PG. Cell death induction by the acute promyelocytic leukemia-specific PML/ RARα fusion protein. Proc Natl Acad Sci U S A. 1997;94:10901-10906.
33. Minucci S, Monestiroli S, Giavara S, et al. PML-RAR induces promyelocytic leukemias with high efficiency following retroviral gene transfer into purified murine hematopoietic progenitors. Blood. 2002;100:2989-2995.